Northern Trust’s Mateon Therapeutics MATN Stock Holding History
Bought
Maintained
Sold
Other funds holding MATN
Northern Trust's MATN Position: Q4 2016 in Review
Northern Trust sold out of Mateon Therapeutics (MATN) in Q4 2016, closing a stake of 25,499 shares — an estimated $16K sold.
Northern Trust first reported a position in MATN in Q2 2016 and held it in 2 quarters. The position peaked at $17K in Q2 2016. 1 fund tracked by Wall St. Rank holds MATN as of Q4 2016.
- Northern Trust reported no remaining Mateon Therapeutics position as of Q4 2016 after selling out during the quarter.
- Northern Trust sold 25,499 Mateon Therapeutics shares in Q4 2016, an estimated $16K.
- Northern Trust first reported a position in Mateon Therapeutics in Q2 2016 and held it in 2 quarters.
- Northern Trust's Mateon Therapeutics position peaked at $17K in Q2 2016.
- 1 fund tracked by Wall St. Rank held Mateon Therapeutics as of Q4 2016.
Based on Northern Trust's 13F filing for Q4 2016, filed 13 Feb 2017.